Frazier Life Sciences Management as of March 31, 2023
Portfolio Holdings for Frazier Life Sciences Management
Frazier Life Sciences Management holds 49 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Hillevax (HLVX) | 11.7 | $162M | 9.8M | 16.53 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 9.1 | $126M | 9.3M | 13.44 | |
| Chinook Therapeutics | 7.3 | $101M | 4.3M | 23.15 | |
| Arcutis Biotherapeutics (ARQT) | 6.9 | $96M | 8.7M | 11.00 | |
| Mirum Pharmaceuticals (MIRM) | 6.7 | $93M | 3.9M | 24.02 | |
| Syndax Pharmaceuticals (SNDX) | 5.7 | $78M | 3.7M | 21.12 | |
| Krystal Biotech (KRYS) | 5.5 | $76M | 945k | 80.06 | |
| Phathom Pharmaceuticals (PHAT) | 4.3 | $60M | 8.4M | 7.14 | |
| Verona Pharma Sponsored Ads (VRNA) | 4.3 | $59M | 2.9M | 20.08 | |
| Vaxcyte (PCVX) | 3.8 | $52M | 1.4M | 37.48 | |
| Rhythm Pharmaceuticals (RYTM) | 2.8 | $39M | 2.2M | 17.84 | |
| Kalvista Pharmaceuticals (KALV) | 1.8 | $26M | 3.2M | 7.86 | |
| Cogent Biosciences (COGT) | 1.7 | $23M | 2.2M | 10.79 | |
| Alpine Immune Sciences (ALPN) | 1.7 | $23M | 3.0M | 7.72 | |
| Tyra Biosciences (TYRA) | 1.7 | $23M | 1.4M | 16.07 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.6 | $23M | 1.4M | 16.06 | |
| Tarsus Pharmaceuticals (TARS) | 1.6 | $23M | 1.8M | 12.57 | |
| Theseus Pharmaceuticals | 1.4 | $20M | 2.2M | 8.88 | |
| Anaptysbio Inc Common (ANAB) | 1.4 | $20M | 900k | 21.76 | |
| Bridgebio Pharma (BBIO) | 1.4 | $19M | 1.2M | 16.58 | |
| Revolution Medicines (RVMD) | 1.3 | $19M | 855k | 21.66 | |
| Enliven Therapeutics (ELVN) | 1.3 | $18M | 831k | 21.90 | |
| ACADIA Pharmaceuticals (ACAD) | 1.2 | $16M | 857k | 18.82 | |
| Gritstone Oncology Ord (GRTS) | 1.0 | $14M | 5.2M | 2.78 | |
| Merus N V (MRUS) | 1.0 | $14M | 747k | 18.40 | |
| Trevi Therapeutics (TRVI) | 0.9 | $12M | 6.7M | 1.85 | |
| Macrogenics (MGNX) | 0.9 | $12M | 1.7M | 7.17 | |
| Replimune Group (REPL) | 0.9 | $12M | 687k | 17.66 | |
| Vectivbio Hldg Ord Shs | 0.8 | $12M | 1.4M | 8.60 | |
| Cerevel Therapeutics Hldng I (CERE) | 0.7 | $9.6M | 393k | 24.39 | |
| Immunovant (IMVT) | 0.7 | $9.1M | 586k | 15.51 | |
| Sutro Biopharma (STRO) | 0.6 | $8.2M | 1.8M | 4.62 | |
| Morphic Hldg (MORF) | 0.6 | $8.1M | 214k | 37.64 | |
| Arvinas Ord (ARVN) | 0.6 | $7.8M | 285k | 27.32 | |
| Avidity Biosciences Ord (RNA) | 0.6 | $7.7M | 500k | 15.35 | |
| Intellia Therapeutics (NTLA) | 0.5 | $7.6M | 204k | 37.27 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.5 | $6.9M | 3.7M | 1.84 | |
| Aerovate Therapeutics (AVTE) | 0.5 | $6.8M | 338k | 20.17 | |
| Prothena Corp SHS (PRTA) | 0.4 | $6.2M | 128k | 48.47 | |
| Zymeworks Del (ZYME) | 0.4 | $5.5M | 610k | 9.04 | |
| Silence Therapeutics Ads (SLN) | 0.4 | $5.5M | 881k | 6.20 | |
| Allakos (ALLK) | 0.4 | $5.0M | 1.1M | 4.45 | |
| Bluebird Bio (BLUE) | 0.3 | $4.6M | 1.4M | 3.18 | |
| Edgewise Therapeutics (EWTX) | 0.3 | $4.6M | 683k | 6.67 | |
| Passage Bio (PASG) | 0.3 | $3.6M | 3.8M | 0.96 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.2 | $3.2M | 1.6M | 1.95 | |
| Aclaris Therapeutics (ACRS) | 0.2 | $2.1M | 264k | 8.09 | |
| Newamsterdam Pharma Company *w Exp 11/22/202 (NAMSW) | 0.1 | $921k | 500k | 1.84 | |
| Nabriva Therapeutics Shs New 2022 (NBRVF) | 0.0 | $30k | 17k | 1.75 |
